Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease

Marketed drugs for Parkinson's disease (PD) treat disease motor symptoms but are ineffective in stopping or slowing disease progression. In the quest of novel pharmacological approaches that may target disease progression, drug-repurposing provides a strategy to accelerate the preclinical and c...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurotherapeutics 2022-01, Vol.19 (1), p.305
Hauptverfasser:	Palmas, Maria Francesca, Ena, Anna, Burgaletto, Chiara, Casu, Maria Antonietta, Cantarella, Giuseppina, Carboni, Ezio, Etzi, Michela, De Simone, Alfonso, Fusco, Giuliana, Cardia, Maria Cristina, Lai, Francesco, Picci, Luca, Tweedie, David, Scerba, Michael T, Coroneo, Valentina, Bernardini, Renato, Greig, Nigel H, Pisanu, Augusta, Carta, Anna R
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!